3042B |
Metolazone, Blood |
3042SP |
Metolazone, Serum/Plasma |
3043B |
Metoprolol, Blood |
3043FL |
Metoprolol, Fluid |
3043SP |
Metoprolol, Serum/Plasma |
3043U |
Metoprolol, Urine |
3064B |
Mitragynine, Blood |
3064SP |
Mitragynine, Serum/Plasma |
3078U |
Mitragynine (Qualitative), Urine |
3103B |
Nadolol, Blood |
3103SP |
Nadolol, Serum/Plasma |
3103U |
Nadolol, Urine |
3158B |
Nifedipine, Blood |
3158SP |
Nifedipine, Serum/Plasma |
3168B |
Nitazenes Panel, Blood |
3218B |
N,N-Dimethylpentylone & Pentylone, Blood |
3218SP |
N,N-Dimethylpentylone & Pentylone, Serum/Plasma |
3218U |
N,N-Dimethylpentylone & Pentylone, Urine |
3224B |
NPS Stimulants (Qualitative), Blood |
3224SP |
NPS Stimulants (Qualitative), Serum/Plasma |
3224U |
NPS Stimulants (Qualitative), Urine |
3426B |
Perfluorooctanoic Acid, Blood Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3427SP |
Perfluoroalkyl Substances (PFAS), Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3428SP |
PFASure TM, Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3429SP |
PFASure TM Expanded, Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3788B |
Prazosin, Blood |
3788SP |
Prazosin, Serum/Plasma |